These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31464386)

  • 21. Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study.
    Lam S; Lin Y; Zinn P; Su J; Pan IW
    J Clin Neurosci; 2018 Jan; 47():285-293. PubMed ID: 29102237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival of patients with glioblastoma multiforme (GBM).
    Smoll NR; Schaller K; Gautschi OP
    J Clin Neurosci; 2013 May; 20(5):670-5. PubMed ID: 23352352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival Analysis of Glioblastoma Multiforme.
    Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 2 Diabetes Mellitus and Glioblastoma Multiforme-Assessing Risk and Survival: Results of a Large Retrospective Study and Systematic Review of the Literature.
    Barami K; Lyon L; Conell C
    World Neurosurg; 2017 Oct; 106():300-307. PubMed ID: 28698089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
    Norden AD; Korytowsky B; You M; Kim Le T; Dastani H; Bobiak S; Singh P
    J Manag Care Spec Pharm; 2019 Apr; 25(4):428-436. PubMed ID: 30917077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved 3-year survival rates for glioblastoma multiforme are associated with trends in treatment: analysis of the national cancer database from 2004 to 2013.
    Zreik J; Moinuddin FM; Yolcu YU; Alvi MA; Chaichana KL; Quinones-Hinojosa A; Bydon M
    J Neurooncol; 2020 May; 148(1):69-79. PubMed ID: 32363470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.
    Barnholtz-Sloan JS; Maldonado JL; Williams VL; Curry WT; Rodkey EA; Barker FG; Sloan AE
    J Neurooncol; 2007 Nov; 85(2):171-80. PubMed ID: 17530174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients.
    Oh T; Rutkowski MJ; Safaee M; Sun MZ; Sayegh ET; Bloch O; Tihan T; Parsa AT
    J Clin Neurosci; 2014 Dec; 21(12):2129-34. PubMed ID: 25037316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGFR amplification is a real independent prognostic impact factor between young adults and adults over 45yo with wild-type glioblastoma?
    Armocida D; Pesce A; Frati A; Santoro A; Salvati M
    J Neurooncol; 2020 Jan; 146(2):275-284. PubMed ID: 31889239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
    Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioblastoma patients' survival and its relevant risk factors during the pre-COVID-19 and post-COVID-19 pandemic: real-world cohort study in the USA and China.
    Qin L; Li H; Zheng D; Lin S; Ren X
    Int J Surg; 2024 May; 110(5):2939-2949. PubMed ID: 38376848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is temporal muscle thickness a survival predictor in newly diagnosed glioblastoma multiforme?
    Yesil Cinkir H; Colakoglu Er H
    Asia Pac J Clin Oncol; 2020 Oct; 16(5):e223-e227. PubMed ID: 32762134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.
    Jin MC; Wu A; Xiang M; Azad TD; Soltys SG; Li G; Pollom EL
    World Neurosurg; 2019 Aug; 128():e217-e224. PubMed ID: 31009783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.
    Zhou M; Chaudhury B; Hall LO; Goldgof DB; Gillies RJ; Gatenby RA
    J Magn Reson Imaging; 2017 Jul; 46(1):115-123. PubMed ID: 27678245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries.
    Efremov L; Abera SF; Bedir A; Vordermark D; Medenwald D
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3381-3390. PubMed ID: 33743072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme.
    Bambury RM; Teo MY; Power DG; Yusuf A; Murray S; Battley JE; Drake C; O'Dea P; Bermingham N; Keohane C; Grossman SA; Moylan EJ; O'Reilly S
    J Neurooncol; 2013 Aug; 114(1):149-54. PubMed ID: 23780645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
    Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
    World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
    Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
    World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.
    Glaser SM; Dohopolski MJ; Balasubramani GK; Flickinger JC; Beriwal S
    J Neurooncol; 2017 Aug; 134(1):107-118. PubMed ID: 28527010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.